Submit to BMT
Cite this article
62
Download
1961
Views
Journal Browser
Volume | Year
Issue
Search
Forthcoming Issue
Current Issue
View All
News and Announcements
View All
COMMENTARY

Biomimetic rhythm programming and intelligent delivery: The BRIGHT transdermal patch revolutionizes chronotherapy for growth hormone treatment

Xiaoyan Qin1 ,  Ni Jiang1* ,  Chaoyong Liu1*
Show Less
1 College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China
BMT 2025, 6(2), 226–229; https://doi.org/10.12336/bmt.25.00015
Submitted: 9 April 2025 | Revised: 6 May 2025 | Accepted: 9 May 2025 | Published: 5 June 2025
© 2025 by the Author(s). Licensee Biomaterials Translational, USA. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 (CC BY-NC-SA 4.0) (https://creativecommons.org/licenses/by-nc-sa/4.0/deed.en)
Download PDF
Cite
XML
Funding
This work was supported by the Beijing Natural Science Foundation- Changping Innovation Joint Fund (L234016).
Conflict of interest
The authors declare no conflicts of interest.
References
[1]
  1. Maury E, Navez B, Brichard SM. Circadian clock dysfunction in human omental fat links obesity to metabolic inflammation. Nat Commun. 2021;12:2388. doi: 10.1038/s41467-021-22571-9

 

  1. Chaput JP, McHill AW, Cox RC, et al. The role of insufficient sleep and circadian misalignment in obesity. Nat Rev Endocrinol. 2023;19:82-97. doi: 10.1038/s41574-022-00747-7

 

  1. Wei Y, Wang Y, Kang A, et al. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles. Mol Pharm. 2012;9:2039-2048. doi: 10.1021/mp300126t

 

  1. Cotterill AM, Holly JM, Snodgrass GA, Savage MO. Regulation of growth hormone secretion in patients with growth hormone insensitivity. Acta Paediatr Scand Suppl. 1991;377:92-95. doi: 10.1111/apa.1991.80.s377.92

 

  1. Li B, Wang X, Yang C, et al. Human growth hormone proteoform pattern changes in pituitary adenomas: Potential biomarkers for 3P medical approaches. EPMA J. 2021;12:67-89. doi: 10.1007/s13167-021-00232-7

 

  1. Liao S, Vickers MH, Evans A, Stanley JL, Baker PN, Perry JK. Comparison of pulsatile vs. Continuous administration of human placental growth hormone in female C57BL/6J mice. Endocrine. 2016;54:169-181. doi: 10.1007/s12020-016-1060-0

 

  1. Hindmarsh PC, Matthews DR, Brook CG. Growth hormone secretion in children determined by time series analysis. Clin Endocrinol (Oxf). 1988;29:35-44. doi: 10.1111/j.1365-2265.1988.tb00247.x

 

  1. Su PH, Malik S, Jheeta A, et al. Investigating the impact of the TUITEK® patient support programme, designed to support caregivers of children prescribed recombinant human growth hormone treatment in taiwan. Front Endocrinol (Lausanne). 2022;13:897956. doi: 10.3389/fendo.2022.897956

 

  1. Han J, Wu Z, Zhan S, et al. Biorhythm-mimicking growth hormone patch. Nat Mater. 2025. doi: 10.1038/s41563-025-02188-9

 

  1. Jang D, Tang J, Schwendeman SP, Prausnitz MR. Effect of surface interactions on microsphere loading in dissolving microneedle patches. ACS Appl Mater Interfaces. 2022;14:29577-29587. doi: 10.1021/acsami.2c05795

 

  1. Li S, Xia D, Prausnitz MR. Efficient drug delivery into skin using a biphasic dissolvable microneedle patch with water-insoluble backing. Adv Funct Mater. 2021;31:2103359. doi: 10.1002/adfm.202103359

 

  1. Fan L, Zhang X, Nie M, et al. Photothermal responsive microspheres-triggered separable microneedles for versatile drug delivery. Advan Functional Mater. 2022;32:2110746. doi: 10.1002/adfm.202110746

 

  1. Meng E, Hoang T. MEMS-enabled implantable drug infusion pumps for laboratory animal research, preclinical, and clinical applications. Adv Drug Deliv Rev. 2012;64:1628-1638. doi: 10.1016/j.addr.2012.08.006

 

  1. Verma RK, Arora S, Garg S. Osmotic pumps in drug delivery. Crit Rev Ther Drug Carrier Syst. 2004;21:477-520. doi: 10.1615/critrevtherdrugcarriersyst.v21.i6.20

 

  1. Gungor-Ozkerim PS, Balkan T, Kose GT, Sarac AS, Kok FN. Incorporation of growth factor loaded microspheres into polymeric electrospun nanofibers for tissue engineering applications. J Biomed Mater Res A. 2014;102:1897-1908. doi: 10.1002/jbm.a.34857

 

  1. Alten R. Chronotherapy with modified-release prednisone in patients with rheumatoid arthritis. Expert Rev Clin Immunol. 2012;8:123-133. doi: 10.1586/eci.11.95

 

  1. Yang R, Yang Z, Chi J, Zhu Y. Insulin delivery devices in diabetes management: Applications and advancements. Intell Pharm. 2025. doi: 10.1016/j.ipha.2025.02.002

 

  1. Lévi F, Okyar A, Dulong S, Innominato PF, Clairambault J. Circadian timing in cancer treatments. Annu Rev Pharmacol Toxicol. 2010;50:377-421. doi: 10.1146/annurev.pharmtox.48.113006.094626

 

  1. Van Cauter E, Kerkhofs M, Caufriez A, Van Onderbergen A, Thorner MO, Copinschi G. A quantitative estimation of growth hormone secretion in normal man: Reproducibility and relation to sleep and time of day. J Clin Endocrinol Metab. 1992;74:1441-1450. doi: 10.1210/jcem.74.6.1592892

 

  1. Van Cauter E, Plat L. Physiology of growth hormone secretion during sleep. J Pediatr. 1996;128:S32-S37. doi: 10.1016/s0022-3476(96)70008-2

 

  1. Arya J, Henry S, Kalluri H, McAllister DV, Pewin WP, Prausnitz MR. Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects. Biomaterials. 2017;128:1-7. doi: 10.1016/j.biomaterials.2017.02.040

 

  1. Forster AH, Witham K, Depelsenaire ACI, et al. Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial. PLoS Med. 2020;17:e1003024. doi: 10.1371/journal.pmed.1003024

 

  1. Sabbagh F, Kim BS. Microneedles for transdermal drug delivery using clay-based composites. Expert Opin Drug Deliv. 2022;19:1099-1113. doi: 10.1080/17425247.2022.2119220

 

  1. Al-Japairai KA, Mahmood S, Hamed Almurisi S, et al. Current trends in polymer microneedle for transdermal drug delivery. Int J Pharm. 2020;587:119673. doi: 10.1016/j.ijpharm.2020.119673

 

  1. Veldhuis JD, Roemmich JN, Richmond EJ, Bowers CY. Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition. Endocr Rev. 2006;27:101-140. doi: 10.1210/er.2005-0006

 

  1. Thakor AS, Gambhir SS. Nanooncology: The future of cancer diagnosis and therapy. CA Cancer J Clin. 2013;63:395-418. doi: 10.3322/caac.21199

 

  1. Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28:5-24. doi: 10.1016/s0169-409x(97)00048-3
Share
Back to top
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept